Large gap with delayed quotes
|
Last quote
01/02/2026
-
17:10:54
|
Bid
01/02/2026 -
17:13:34
|
Bid Volume |
Ask
01/02/2026 -
17:13:34
|
Ask Volume |
|---|---|---|---|---|
|
178.78
+5.24
(
+3.02% )
|
179.00
|
100 |
179.68
|
100 |
Analysis date: 31.12.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 09.12.2025.
Interest
Very strong
Very strong
Four stars since 26.12.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 26.12.2025 at a price of 164.84.
Evaluation
Neutral
Neutral
Based on its growth potential and our own criteria, we believe the share price is currently fairly priced.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 12.12.2025.
4wk Rel Perf
17.10%
17.10%
The four-week dividend-adjusted overperformance versus SP500 is 17.10%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 04.07.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -1.38%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 5.22%.
Mkt Cap in $bn
8.77
8.77
With a market capitalization >$8bn, MOLINA HEALTHCARE is considered a large-cap stock.
G/PE Ratio
0.95
0.95
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
10.59
10.59
The estimated PE is for the year 2027.
LT Growth
10.09%
10.09%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
17
17
Over the last seven weeks, an average of 17 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
-29
-29
For 1% of index variation, the stock varies on average by -0.29%.
Correlation
-0.10
-0.10
Stock movements are strongly independent of index variations, with an even divergent trend.
Value at Risk
50.24
50.24
The value at risk is estimated at USD 50.24. The risk is therefore 28.95%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
28.07.2004
28.07.2004